Super Computing 2016 brought into sharp focus the powerful impact HPC is having on everything from life sciences and research to machine learning.
Life Sciences simulation and modeling are breaking new ground in cancer research, drug development, patient screening, and visualization based on high-performance Intel® Xeon Phi™ processors and th
HPC resources add scale and power for clinical care and research that extends well beyond the drug development pipeline.
LAMMPS* 3D molecular dynamics simulations are used to analyze, visualize, and manipulate the high-resolution 3D molecular structure of proteins and simulate its movement and interaction.
The ROME System was developed at the Dana Farber Cancer Institute and Harvard Medical School and funded in part by Intel® Parallel Computing Centers.
QIAGEN performs genome sequencing and analyzes the sequenced DNA to help identify patients who have variants of interest compared to a reference genome, and thus could have the protein that the cry
This demo highlights research performed at Kyoto University Graduate School of Medicine with a dataset of more than 400 million proteins.